PeerView | Emergency Medicine

Free CME from PeerView

Emergency Medicine CME

The Medical College of Wisconsin

New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics

Corey Cutler, MD, MPH, FRCP(C) / Miguel-Angel Perales, MD

February 23, 2021

The Medical College of Wisconsin

Betting on CAR-T Cell Therapy: Expert Perspectives on Effective Integration Strategies and Achieving Improved Outcomes Across Hematologic Cancers

Michael R. Bishop, MD

February 18, 2021

The Medical College of Wisconsin

The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT

Robert Z. Orlowski, MD, PhD

February 17, 2021

The Medical College of Wisconsin

Charting Progress in AML Care: A Clinical CaseBook on the Intersection of Novel Therapy and Allogeneic HCT

February 16, 2021

Medical Learning Institute, Inc.

Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care

Reynold A. Panettieri, Jr., MD

February 15, 2021

Medical Learning Institute, Inc.

Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes

Stephen V. Liu, MD

February 12, 2021

Medical Learning Institute, Inc.

Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes

Rishi P. Singh, MD

February 12, 2021

Medical Learning Institute, Inc.

A New Dawn in the Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With New and Emerging Targeted Strategies

Milind Javle, MD

February 11, 2021

Medical Learning Institute, Inc.

How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches

Richard S. Finn, MD

February 09, 2021

Medical Learning Institute, Inc.

Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies

Axel Grothey, MD

February 08, 2021

Pages